New Study: COVID-19 Testing Costs Could Reach $25 Billion a Year for Diagnostic, $19 Billion a Year for Antibody

Every American should be able to get the COVID-19 tests they need. As businesses and the health care system prepare to safely reopen, leaders are looking for answers to determine what testing strategies will best protect against spread of the virus, how much these strategies may cost American taxpayers and health care consumers, and what investments might be necessary moving forward.

To help inform reopen strategies, AHIP retained Wakely Consulting Group to explore the potential costs of COVID-19 testing, including both diagnostic (molecular or antigen) and antibody testing considering different frequencies and costs of testing. The study found that diagnostic